A Phase 2 Randomized, Controlled, Blinded Study in a Single Center Using Omalizumab With Oral Food Immunotherapy in Children and Adults With Multiple Food Allergies

Trial Profile

A Phase 2 Randomized, Controlled, Blinded Study in a Single Center Using Omalizumab With Oral Food Immunotherapy in Children and Adults With Multiple Food Allergies

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2014

At a glance

  • Drugs Omalizumab (Primary) ; Food allergy immunotherapy
  • Indications Food hypersensitivity
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 15 Apr 2014 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 12 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top